(European Society of Cardiology) Sildenafil should not be used to treat residual hypertension in patients with valvular heart disease, according to late-breaking results from the SIOVAC trial presented today in a Hot Line LBCT Session at ESC Congress. The off-label use of the drug led to worse clinical outcomes including a doubled risk of hospitalization compared to placebo.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2vlruJ7
No comments:
Post a Comment